• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

副肿瘤性神经系统综合征中的调节性T细胞。

Regulatory T cells in paraneoplastic neurological syndromes.

作者信息

Tani Takashi, Tanaka Keiko, Idezuka Jiro, Nishizawa Masatoyo

机构信息

Neurology, Brain Research Institute of Niigata University, Asahimachi Dori 1-757, Niigata-shi, Niigata, Japan.

出版信息

J Neuroimmunol. 2008 May 30;196(1-2):166-9. doi: 10.1016/j.jneuroim.2008.03.002. Epub 2008 May 1.

DOI:10.1016/j.jneuroim.2008.03.002
PMID:18455243
Abstract

Focusing on CD4(+)CD25(+) regulatory T lymphocytes (T(reg)), we studied the gene expression of T(reg) functional molecules in peripheral blood lymphocytes of patients with paraneoplastic neurological syndrome (PNS), including Lambert-Eaton myasthenic syndrome (LEMS) with small cell lung carcinoma (SCLC) and anti-Hu- or anti-Yo-antibody-positive PNS. T(reg)-rich subsets were sorted from the patients' peripheral blood mononuclear cells, and the mRNA expression levels of their functional genes were measured. The expression levels of FOXP3, TGF-beta and CTLA4 mRNA in T(reg)-rich subsets of PNS patients were down-regulated compared with that of SCLC patients without PNS. These results suggest that T(reg) dysfunction plays a role in PNS development.

摘要

聚焦于CD4(+)CD25(+)调节性T淋巴细胞(T(reg)),我们研究了副肿瘤性神经综合征(PNS)患者外周血淋巴细胞中T(reg)功能分子的基因表达,这些患者包括合并小细胞肺癌(SCLC)的兰伯特-伊顿肌无力综合征(LEMS)以及抗Hu或抗Yo抗体阳性的PNS患者。从患者外周血单个核细胞中分离出富含T(reg)的亚群,并测定其功能基因的mRNA表达水平。与无PNS的SCLC患者相比,PNS患者富含T(reg)亚群中FOXP3、TGF-β和CTLA4 mRNA的表达水平下调。这些结果表明T(reg)功能障碍在PNS的发生发展中起作用。

相似文献

1
Regulatory T cells in paraneoplastic neurological syndromes.副肿瘤性神经系统综合征中的调节性T细胞。
J Neuroimmunol. 2008 May 30;196(1-2):166-9. doi: 10.1016/j.jneuroim.2008.03.002. Epub 2008 May 1.
2
The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.过敏性鼻炎和支气管哮喘患儿中CD4+CD25+调节性T细胞的水平。
Clin Exp Immunol. 2007 Apr;148(1):53-63. doi: 10.1111/j.1365-2249.2007.03329.x.
3
No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.在副肿瘤性神经系统综合征和Hu抗体患者中,没有证据表明存在循环的HuD特异性CD8 + T细胞。
Cancer Immunol Immunother. 2007 Sep;56(9):1501-6. doi: 10.1007/s00262-007-0295-2. Epub 2007 Feb 14.
4
Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.小鼠和人类中Foxp3(+) γδ T细胞的鉴定与特征分析
Immunol Lett. 2009 Aug 15;125(2):105-13. doi: 10.1016/j.imlet.2009.06.005. Epub 2009 Jun 17.
5
Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.骨髓基质细胞在人类CD8 + 调节性T细胞生成中的作用。
Hum Immunol. 2008 Nov;69(11):755-9. doi: 10.1016/j.humimm.2008.08.278. Epub 2008 Sep 24.
6
[The role of CD4+CD25+ regulatory T cells in the pathogenesis of chronic abacterial prostatitis/chronic pelvic pain syndrome].[CD4+CD25+调节性T细胞在慢性非细菌性前列腺炎/慢性盆腔疼痛综合征发病机制中的作用]
Zhonghua Yi Xue Za Zhi. 2008 Nov 4;88(40):2838-41.
7
Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.变应性哮喘患者的CD4+CD25+调节性T细胞在体外经变应原刺激后增殖不足。
Int Arch Allergy Immunol. 2009;148(3):199-210. doi: 10.1159/000161580. Epub 2008 Oct 10.
8
[Analysis of CD4+CD25+Foxp3+ regulatory T cells in patients of haemorrhagic fever with renal syndrome].肾综合征出血热患者CD4+CD25+Foxp3+调节性T细胞分析
Zhonghua Yi Xue Za Zhi. 2009 Mar 31;89(12):817-9.
9
Immunosuppression during active tuberculosis is characterized by decreased interferon- gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor- beta , and interleukin-4 mRNA levels.活动性肺结核期间的免疫抑制特征为干扰素-γ产生减少、CD25表达降低,同时叉头框蛋白P3、转化生长因子-β和白细胞介素-4的mRNA水平升高。
J Infect Dis. 2007 Mar 15;195(6):870-8. doi: 10.1086/511277. Epub 2007 Feb 1.
10
Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.高效抗逆转录病毒治疗(HAART)下HIV-1感染者CD4+CD25+调节性T细胞中免疫激活程度、白细胞介素-2产生与叉头框蛋白P3(FOXP3)表达之间的相关性
Int Immunopharmacol. 2009 Jul;9(7-8):831-6. doi: 10.1016/j.intimp.2009.03.009. Epub 2009 Mar 18.

引用本文的文献

1
Paraneoplastic neurological syndromes of small cell lung cancer.小细胞肺癌的副肿瘤性神经系统综合征
Postep Psychiatr Neurol. 2024 Jun;33(2):80-92. doi: 10.5114/ppn.2024.141157. Epub 2024 Jul 11.
2
Paraneoplastic Cerebellar Degeneration Associated with Breast Cancer: A Case Report and a Narrative Review.与乳腺癌相关的副肿瘤性小脑变性:一例报告及文献综述
Brain Sci. 2024 Feb 14;14(2):176. doi: 10.3390/brainsci14020176.
3
Small-cell Lung Carcinoma with Gastrointestinal Pseudo-obstruction as a Paraneoplastic Neurological Syndrome Elicited by an Immune Checkpoint Inhibitor.
免疫检查点抑制剂诱发的小细胞肺癌伴胃肠假性梗阻:一种副瘤性神经系统综合征
Intern Med. 2024 Jul 15;63(14):2059-2062. doi: 10.2169/internalmedicine.2648-23. Epub 2023 Dec 4.
4
Low-dose interleukin-2 as a novel therapeutic option for refractory paraneoplastic neurologic syndrome: a case of chronic relapsing anti-Ma2/Ta paraneoplastic myeloradiculopathy.低剂量白细胞介素-2作为难治性副肿瘤性神经系统综合征的一种新治疗选择:一例慢性复发性抗Ma2/Ta副肿瘤性脊髓神经根病病例
Encephalitis. 2021 Jul;1(3):79-84. doi: 10.47936/encephalitis.2021.00038. Epub 2021 Apr 27.
5
Lung cancer immunotherapy: progress, pitfalls, and promises.肺癌免疫疗法:进展、陷阱和前景。
Mol Cancer. 2023 Feb 21;22(1):40. doi: 10.1186/s12943-023-01740-y.
6
History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature.广泛期小细胞肺癌治疗史:是时候提高标准了?文献综述
Cancers (Basel). 2021 Feb 27;13(5):998. doi: 10.3390/cancers13050998.
7
Pathology and Classification of SCLC.小细胞肺癌的病理学与分类
Cancers (Basel). 2021 Feb 16;13(4):820. doi: 10.3390/cancers13040820.
8
Paraneoplastic Sensory Polyneuropathy Related to Anti-PD-L1-including Anticancer Treatment in a Patient with Lung Cancer.肺癌患者接受含抗 PD-L1 药物的抗肿瘤治疗后出现副肿瘤感觉性多神经病。
Intern Med. 2021 May 15;60(10):1577-1581. doi: 10.2169/internalmedicine.5629-20. Epub 2020 Dec 15.
9
Immune checkpoint inhibitors in small cell lung cancer.小细胞肺癌中的免疫检查点抑制剂
J Thorac Dis. 2018 Feb;10(Suppl 3):S460-S467. doi: 10.21037/jtd.2017.12.51.
10
The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.免疫疗法在小细胞肺癌治疗中的未来
Oncologist. 2016 Aug;21(8):910-21. doi: 10.1634/theoncologist.2015-0523. Epub 2016 Jun 27.